The BBC has announced the cast for SAS: Rogue Heroes, Peaky Blinders creator Steven Knight’s dramatized account of how Britain’s Special Forces unit was formed in the darkest days of World War Two. Connor Swindells (Sex Education) will play David Stirling, with Jack O’Connell (The North Water) as Paddy Mayne, Alfie Allen (Game Of Thrones) […]
Crown Publishing Group has "paused active support" of New York Gov. Andrew Cuomo's book on leadership lessons from the pandemic and has "no plans to reprint or reissue in paperback," citing a federal investigation into Cuomo's handling of COVID-19 in nursing homes, the New York Times reports.Why it matters: The embattled governor, who is simultaneously facing several allegations of sexual harassment, was heavily criticized for his decision to publish a book last October about his response to the coronavirus, as the pandemic was still raging.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeThe big picture: Cuomo's book, “American Crisis: Leadership Lessons from the Covid-19 Pandemic," was vaulted to the top of best-seller lists after the New York governor became a popular national figure for his daily coronavirus briefings.But over the last two months, as it was revealed that the Cuomo administration concealed the true number of coronavirus deaths in nursing homes, book sales have slowed to a crawl.According to the Times, Cuomo defends his nursing home policy in one chapter of the book, writing that "New York was No. 46 out of 50 in the nation when it came to percentage of deaths in nursing homes" and accusing critics of politically motivated attacks.But the state's true ranking would have been much higher if officials hadn't undercounted the number of deaths in nursing homes by as much as 50%, according to a report by the New York attorney general.Go deeper: Cuomo advisers reportedly altered July COVID-19 nursing homes reportMore from Axios: Sign up to get the latest market trends with Axios Markets. Subscribe for free
Robotic-assisted surgical device developer Intuitive Surgical (NASDAQ: ISRG) is a company that investors can buy with confidence. With the entire healthcare sector focused on precision medicine, demand for the company's da Vinci surgical systems should continue to grow over time. What's interesting about Intuitive Surgical is just how dominant its surgical-assisted robotic platform actually is.